He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of US $202 mn in the US
Under the PMBJP, till 30.06.2022, 8742 PMBJKs have been opened across the country including Government Hospitals and Government premises.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
The product will be launched by NATCO's commercial partner Viatris.
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Subscribe To Our Newsletter & Stay Updated
